BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3130623)

  • 1. Proteolytic dissection of a hapten binding site.
    Sen J; Beychok S
    Proteins; 1986 Nov; 1(3):256-62. PubMed ID: 3130623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for both H and L chain V regions, VH and VK joining amino acids, and the unique H chain D region for the high affinity binding of an anti-phosphotyrosine antibody.
    Ruff-Jamison S; Glenney JR
    J Immunol; 1993 Apr; 150(8 Pt 1):3389-96. PubMed ID: 7682239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modeled structure of the IgG Gar VL region and its implications for anti-flavin and anti-DNP fine specificities.
    Kiefer CR; McGuire BS; Osserman EF; Garver FA
    J Immunol; 1983 Oct; 131(4):1871-5. PubMed ID: 6413582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of interface framework residues in determining antibody V(H)/V(L) interaction strength and antigen-binding affinity.
    Masuda K; Sakamoto K; Kojima M; Aburatani T; Ueda T; Ueda H
    FEBS J; 2006 May; 273(10):2184-94. PubMed ID: 16649995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
    Chen Y; Stollar BD
    J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complete V domain amino acid sequences of two myeloma inulin-binding proteins.
    Johnson N; Slankard J; Paul L; Hood L
    J Immunol; 1982 Jan; 128(1):302-7. PubMed ID: 6798111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance.
    Polymenis M; Stollar BD
    J Immunol; 1995 Mar; 154(5):2198-208. PubMed ID: 7868893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heavy chain variable region, light chain variable region, and heavy chain CDR3 influences on the mono- and polyreactivity and on the affinity of human monoclonal rheumatoid factors.
    Crouzier R; Martin T; Pasquali JL
    J Immunol; 1995 May; 154(9):4526-35. PubMed ID: 7722307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational changes in the antibody constant domains upon hapten-binding.
    Sagawa T; Oda M; Morii H; Takizawa H; Kozono H; Azuma T
    Mol Immunol; 2005 Jan; 42(1):9-18. PubMed ID: 15488939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of the gp120 superantigen-binding site on human immunoglobulins.
    Karray S; Juompan L; Maroun RC; Isenberg D; Silverman GJ; Zouali M
    J Immunol; 1998 Dec; 161(12):6681-8. PubMed ID: 9862697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR analysis of the interaction between protein L and Ig light chains.
    Enokizono J; Wikström M; Sjöbring U; Björck L; Forsén S; Arata Y; Kato K; Shimada I
    J Mol Biol; 1997 Jul; 270(1):8-13. PubMed ID: 9231896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of the immunoglobulin light chain-binding site of protein L.
    Wikström M; Sjöbring U; Drakenberg T; Forsén S; Björck L
    J Mol Biol; 1995 Jul; 250(2):128-33. PubMed ID: 7608965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the effect of changes in conformation and compactness at the antibody V(L)-V(H) interface upon antigen binding.
    Pellequer JL; Chen Sw; Roberts VA; Tainer JA; Getzoff ED
    J Mol Recognit; 1999; 12(4):267-75. PubMed ID: 10440998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical binding site amino acids of anti-Z-DNA single chain Fv molecules. Role of heavy and light chain CDR3 and relationship to autoantibody activity.
    Polymenis M; Stollar BD
    J Immunol; 1994 Jun; 152(11):5318-29. PubMed ID: 8189049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity.
    Thompson J; Pope T; Tung JS; Chan C; Hollis G; Mark G; Johnson KS
    J Mol Biol; 1996 Feb; 256(1):77-88. PubMed ID: 8609615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation.
    Figini M; Marks JD; Winter G; Griffiths AD
    J Mol Biol; 1994 May; 239(1):68-78. PubMed ID: 8196048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
    Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
    J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conserved amino acid networks involved in antibody variable domain interactions.
    Wang N; Smith WF; Miller BR; Aivazian D; Lugovskoy AA; Reff ME; Glaser SM; Croner LJ; Demarest SJ
    Proteins; 2009 Jul; 76(1):99-114. PubMed ID: 19089973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.